pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Hollings researcher receives grant to fight complications after pediatric bone marrow transplant

MUSC Hollings Cancer Center researcher Sophie Paczesny, M.D., Ph.D., recently received a four-year grant from the National Heart, Lung, and Blood Institute to investigate solutions to help doctors to fight complications after pediatric bone marrow transplantation (BMT).

12 Feb 2022

Researchers shows how ΔNp63 protein contributes to lung cancer development

Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average five-year survival rate of 21.7%.

12 Feb 2022

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Cancer patients undergoing active treatment were more likely to believe misinformation related to COVID-19 than those without a history of cancer, according to a new study led by researchers at Virginia Commonwealth University.

12 Feb 2022

Mechanical clot removal may improve recovery after severe stroke in children

Serious disability was 6 times more likely to be the result three months after stroke among children whose clot-caused stroke in a large vessel (a type of ischemic stroke) was not treated with a procedure to extract the clot, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

When comparing outcomes for acute ischemic stroke patients treated at various levels of stroke centers, patients who received care at Comprehensive Stroke Centers (CSC) or Thrombectomy-capable Stroke Centers (TSC) were more likely to receive rapid treatment with clot-busting medication and/or mechanical clot removal and be discharged home or to rehabilitation centers than patients treated at Primary Stroke Centers, according to preliminary research to be presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

11 Feb 2022

Pharmacological manipulation could restore microglia function after exposure to industrial toxin in utero

New research shows that exposure to the industrial byproduct TCDD in utero could cause the brain's immune system to go array later in life, damaging important brain circuits, and potentially giving rise to neurodevelopmental disorders, such as autism and ADHD.

11 Feb 2022

Novel wearable soft robotic armband could be a game changer for users of prosthetic hands

Typing on a keyboard, pressing buttons on a remote control or braiding a child's hair has remained elusive for prosthetic hand users.

11 Feb 2022

Don’t nurse that Moscow mule — it could be a health hazard

The popular cocktail known as the Moscow mule supposedly gets some of its flavor from the frosty copper mug it's served in — the shiny metal oxidizes slightly and enhances the drink's aroma and effervescence.

11 Feb 2022

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Scientific statement highlights the uncertainty about health effects of marijuana

Despite the perception that marijuana is harmless, there is some scientific evidence challenging that belief, and there are many unanswered questions about its impact on brain health, according to a new American Heart Association scientific statement published today in the Association's journal Stroke.

10 Feb 2022

New analysis highlights growing trends in combination cancer therapy clinical trials

The Cancer Research Institute, a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all types of cancer, announced today the publication of its newest analysis of the global landscape of clinical development of drugs that target the PD1/PDL1 immune checkpoint pathway.

10 Feb 2022

Regular surveillance testing of a community can prevent Covid-19 outbreaks

Covid-19 is often asymptomatic and can lead infected individuals to spread the disease without knowing it. Yet, regular surveillance testing of a community can catch these cases and prevent outbreaks.

10 Feb 2022

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo (DRC) that are experiencing outbreaks of the disease.

10 Feb 2022

Poll: Most people over age 50 aren’t using mobile health-related apps

Mobile apps make it possible to track everything from exercise and calories to blood pressure and blood sugar, and use the information to stay on target with health goals or managing a chronic condition.

9 Feb 2022

Researchers reveal new therapeutic way to block oncogenic RAS mutants

As a 10-year journey comes to fruition, MUSC Hollings Cancer Center researcher John O'Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers.

9 Feb 2022

Mechanical clot removal may be effective and lead to better outcomes for stroke patients

Stroke patients previously considered unlikely to survive without severe disability may regain far more function if the blood clots (which cause an ischemic stroke) are mechanically removed in addition to standard medical therapy, according to preliminary late-breaking research presented today at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health, held in person in New Orleans and virtually, Feb. 9-11, 2022.

9 Feb 2022

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease-; even long after treatment with monoclonal antibodies.

9 Feb 2022

Mayo Clinic and CMU announce research agreement to transform organ transplantation

Mayo Clinic and Carnegie Mellon University (CMU) announced today a research agreement to transform organ transplantation. The institutions will bioengineer innovative approaches to address barriers in organ transplantation.

9 Feb 2022

pH News and Research

Further Reading

Hollings researcher receives grant to fight complications after pediatric bone marrow transplant

Researchers shows how ΔNp63 protein contributes to lung cancer development

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Mechanical clot removal may improve recovery after severe stroke in children

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Pharmacological manipulation could restore microglia function after exposure to industrial toxin in utero

Novel wearable soft robotic armband could be a game changer for users of prosthetic hands

Don’t nurse that Moscow mule — it could be a health hazard

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Scientific statement highlights the uncertainty about health effects of marijuana

New analysis highlights growing trends in combination cancer therapy clinical trials

Regular surveillance testing of a community can prevent Covid-19 outbreaks

Study shows immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in Congolese populations

Poll: Most people over age 50 aren’t using mobile health-related apps

Researchers reveal new therapeutic way to block oncogenic RAS mutants

Mechanical clot removal may be effective and lead to better outcomes for stroke patients

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

Mayo Clinic and CMU announce research agreement to transform organ transplantation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News